BeStock  

Cooper Companies COO

US equityMarket cap rank #1319Medical Instruments & Supplies
$58.88 −$1.45 (-2.40%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $59.53 +1.10%
Open$60.67
Prev close$60.33
Day range$58.66 – $60.98
Volume2.08M
Market cap$11.20B
P/E (TTM)20.2
Dividend yield–

Earnings

Average move on report day±7.4%last 16 reports
Closed higher6 of 1638% of the time
Best reaction+11.8%
Worst reaction-14.7%

Stock move on the day after each report

-2.9%2023/Q4+9.2%2024/Q1+4.5%2024/Q2+11.8%2024/Q3-4.4%2024/Q4-6.6%2025/Q1-14.6%2025/Q2-12.9%2025/Q3+5.7%2025/Q4-4.6%2026/Q1+8.6%2026/Q2-14.7%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q39 Sep 2026After Market±9.1%-14.67%Bigger than priced
2026/Q24 Jun 2026After Market±7.4%+8.58%Bigger than priced
2026/Q15 Mar 2026After Market±7.7%-4.55%Within range
2025/Q44 Dec 2025After Market±8.9%+5.67%Within range
2025/Q327 Aug 2025After Market±9.8%-12.85%Bigger than priced
2025/Q229 May 2025After Market±9.4%-14.61%Bigger than priced
2025/Q16 Mar 2025After Market±8.7%-6.57%Within range
2024/Q45 Dec 2024After Market±8.1%-4.39%Within range
2024/Q328 Aug 2024After Market±8.1%+11.84%Bigger than priced
2024/Q230 May 2024After Market±7.7%+4.52%Within range
2024/Q129 Feb 2024After Market±7.1%+9.18%Bigger than priced
2023/Q47 Dec 2023After Market±5.4%-2.88%Within range
2023/Q330 Aug 2023After Market±5.7%-2.85%Within range
2023/Q21 Jun 2023After Market±5.8%-4.74%Within range
2023/Q12 Mar 2023After Market±6.7%+7.30%Bigger than priced
2022/Q48 Dec 2022After Market±6.2%-3.12%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • CooperVision$717.00M 67.2%
  • CooperSurgical$349.20M 32.8%

Latest reported quarter: Q3, ended Jul 2026

Revenue$1.07B+0.6% YoY
Operating profit$222.00M+26.4% YoY
Net profit$432.80M+340.3% YoY
Diluted EPS$2.24+357.1% YoY
Free cash flow$273.00M+66.0% YoY
Operating cash flow$341.70M

Revenue, last 8 quarters

$1.0BOct '24$964.7MJan '25$1.0BApr '25$1.1BJul '25$1.1BOct '25$1.0BJan '26$1.1BApr '26$1.1BJul '26

Net profit, last 8 quarters

$117.5MOct '24$104.3MJan '25$87.7MApr '25$98.3MJul '25$84.6MOct '25$130.8MJan '26$-77.9MApr '26$432.8MJul '26

Profitability & balance sheet

Gross margin65.9%
Operating margin12.8%
Net margin13.5%
Return on equity6.8%
Return on assets4.6%
Return on invested capital5.7%
Current ratio1.22
Liabilities / assets34.3%
Cash & investments$154.70M
Total debt$2.54B
Net cash (debt)-$2.39B
Free cash flow / sales16.0%

Discussion

No comments yet — be the first to weigh in on COO.

Sign in to join the discussion.

Scroll to Top